Home › Plexiform Neurofibroma › District of Columbia
Pag-aaral pangklinika para sa Plexiform Neurofibroma sa District of Columbia
4 pag-aaral para sa Plexiform Neurofibroma ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Children's National Hospital, Washington D.C.
Nagre-recruitPhase 1
Edad 16 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Children's National Hospital, Washington D.C.
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- Children's National Medical Center, Washington D.C.
Nagre-recruit
Edad 1 hanggang 120 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Children's National Hospital, Washington D.C.
Nagre-recruitPhase 2
Edad 1 hanggang 8 · Lahat ng kasarian · Na-update May 29, 2026 · NCT06188741Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.